CELECOXIB SELECTIVELY TARGETS GENES AND PATHWAYS INVOLVED IN INFLAMMATION AND MALIGNANT TRANSFORMATION IN TUMOR BUT NOT NORMAL CELLS

(1) Integrated Cancer Prevention Center, Tel Aviv Medical Center and Tel Aviv University, Tel Aviv

(2) Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot

(3) Integrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv, Israel



This item was part of the ONCOLOGY III session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A480